Skip to content
Bomb Report – Lifestyle
Author:
Disc Medicine Inc
Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
June 2, 2026
Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
June 1, 2026
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
May 12, 2026
Disc Medicine to Participate in Upcoming Investor Conferences
May 11, 2026
←
Previous Page
1
2